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Human peripheral blood monocytes comprise a subpopulation of 20 to 40% that
is capable of responding to chemoattractants and a remaining subpopulation that
cannot respond. We were able to obtain 99%-pure attractant-responsive mono-
cytes by using a newly constructed separation chamber. The binding of the
radioactive chemotactic peptide N-formylmethionyl-leucyl-[3H]phenylalanine to
migrating and nonmigrating populations was then studied. The binding was
saturable at room temperature in the presence of azide. Saturation occurred at 5 x
10-8 M, and 50% of the maximal binding was obtained at 10-8 M, the concentra-
tion that induced optimal chemotaxis. The nonmigrating monocytes did not bind
the peptide under the same conditions, which shows that at least one reason for a
nonresponsiveness to chemotaxin is apparently a lack of receptors. By Scatchard
analysis we calculated an equilibrium dissociation constant ranging from 23 to 37
nM; the number of binding sites per cell ranged from 64,000 to 77,000. The binding
was very rapid. Fifty percent of the optimnal binding occurred at 3.5 min, and
equilibrium was reached after 20 to 30 min. Chemotactic deactivation of the
monocytes reduced the number of available binding sites by 60%.
Chemotaxis of phagocytes may be important
in the accumulation of effector cells at sites of
inflammation. Receptor-ligand interactions have
been the subject of several recent studies of the
basic mechanisms of chemotaxis. Receptors for
chemotactic peptides have been demonstrated
for human (11, 15) and rabbit (1) polymorphonu-
clear leukocytes and for guinea pig macrophages
(14). A receptor for the chemotactic fragment of
the fifth component of complement, C5a, has
been shown to be on the surface of human
neutrophils (3). None of these studies addresses
the possibility of a nonhomogeneity of the cell
populations with respect to chemotactic respon-
siveness or receptor distribution. We have
shown that only 20 to 40% of human blood
monocytes migrate to chemoattractants and that
each of these migrating cells can respond to
several different attractants (6). This has recent-
ly been confirmed by the finding that only a
subpopulation responds to chemotaxins by po-
larization (4). The human monocyte cell line
U937 exhibits chemotaxis only when a surface
receptor is expressed after induction by lympho-
kines (8, 12). The subject of this paper is the
binding of N-formylmethionyl-leucyl-[3H]phen-
ylalanine (fMet-Leu-[3H]Phe) to migrating and
nonmigrating human monocyte populations. Us-
ing a newly developed method for isolating the
migrating population, we show that only the
migrating cells bind the chemotactic peptide.
This is in contrast to the results of the accompa-
nying paper (10), in which the binding of peptide
to migrating human neutrophils is quantitatively
indistinguishable from the binding of peptide to
nonmigrating human neutrophils.
MATERIALS AND METHODS
Reagents. fMet-Leu-[3H]Phe with a specific activity
of 46.4 Ci/mmol was obtained from New England
Nuclear Corp., Boston, Mass.; sodium azide and
fMet-Leu-Phe were purchased from Sigma Chemical
Co., St. Louis, Mo.
Cell preparation and separation by chemotaxis. Hu-
man blood mononuclear cells were isolated by the
method of Boyum (2) and adjusted to 2 x 106 mono-
cytes per ml. To separate migrating from nonmigrating
monocytes, we used a newly constructed separation
chamber (Neuro Probe Inc., Bethesda, Md.). As in our
48-well chamber (5), upper and lower compartments
were separated by a Nuclepore membrane filter (25
by 80 mm), but the area was divided into only four
large compartments (Fig. 1). The total filter area
available for chemotaxis was 1,350 mm2 (equal to the
filter area of 170 wells of the 48-well chamber). The
volumes of each of the four lower and upper compart-
ments were 1.3 and 2.0 ml, respectively. The lower
compartments were filled with an attractant solution;
the upper compartments were filled with a cell suspen-
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FIG. 1. Cell separation chamber. The chamber is
composed of three parts. The lower plate contains four
compartments for the attractant solution with a vol-
ume of 1.3 ml each. After the compartments are filled
with the attractant solution, a Nuclepore filter sheet
(25 by 80 mm) is applied. This is followed by a silicone
gasket and the top plate, which is bolted in place. The
cell suspension is added to the upper compartments,
which have a volume of 2 ml each.
sion containing not more than 2 x 106 monocytes per
ml. The chamber was then incubated for 70 min at
37°C in moist air containing 5% CO2. By this time,
attractant-responsive monocytes had migrated to the
bottom surface of the filter, where they remained
attached without falling into the lower compartment.
The nonmigrating cells on the top of the filter were
collected by resuspension with a pipette. The filter top
was then wiped with a cotton swab to eliminate
residual cells. The filter was removed and clamped,
with the migrating-cell side exposed, to the inside of a
250-mi polypropylene tube with its neck cut off (no.
25350; Corning Glass Works, Corning, N.Y.). The
migrating cells were rinsed off the filter with medium,
washed once to remove traces of chemotactic factor
and counted. The data on monocyte recovery and
purity are presented below.
Monocyte deactivation. The monocytes were incu-
bated for 45 min at 370C with 5 x 10-7 M fMet-Leu-
Phe at a cell concentration of 2 x 105 monocytes per
ml of Gey balanced salt solution containing 2% bovine
serum albumin. The cells were then washed twice and
used for the binding assay.
Binding assay. The binding of tritiated fMet-Leu-Phe
was assayed as described in the accompanying paper
(10). The cells were suspended in Gey balanced salt
solution containing 2% bovine serum albumin and 1
mM sodium azide to inhibit possible ligand internaliza-
tion (14). Generally, 5 x 105 separated migrating or
nonmigrating monocytes were used per assay point.
The cells were incubated for 30 min at 24°C with
concentrations of the radioactive peptide ranging from
10-9 to 10-7 M, with or without a 100-fold excess of
the nonradioactive peptide. After incubation, the sus-
pensions were filtered through Whatman glass fiber
filters. The filters were washed with 10 ml of cold
Hanks buffered salt solution containing 2% bovine
serum albumin and were placed in scintillation vials
with 10 ml of Ultrafluor scintillation fluid (National
Diagnostics, Sommerville, N.J.). They were allowed
to equilibrate for at least 3 h to obtain maximal counts.
Nonspecific binding, defined as the amount of fMet-
Leu-[3H]Phe bound to the cells when a 100-fold excess
of the nonradioactive peptide was present with the
radioactive peptide, was usually less than 5% of the
total radioactivity bound. Because of this low figure,
all data are presented without correction for nonspe-
cific binding.
RESULTS
Cell separation. No methods have previously
been available to prepare pure monocyte sus-
pensions suitable for chemotaxis assays. In
these studies, we designed a separation chamber
(Fig. 1) to obtain purified monocytes by chemo-
taxis, as described above. The approach was
based on the fact that with Ficoll-Hypaque-
separated cells (comprising monocytes, lympho-
cytes, and approximately 0.5% neutrophils), the
cells that migrated through the pores of a Nu-
clepore filter toward an attractant were almost
exclusively monocytes. The few neutrophils that
migrated fell off the polyvinylpyrrolidone-coated
filters (9). Thus, after 70 min of incubation, the
attractant side of the filter was covered with
monocytes, which were then rinsed off the filter
relatively easily with little mechanical force. No
residual cytoplasmic material was seen on the
filter after it was stained. The purity of the
migrating monocytes was 99 to 100%. No trypan
blue-positive cells were seen, and no gross mor-
phological changes were detected. Typically, 20
to 40% of the input monocytes were recovered
from the filter bottom. This corresponds to the
migration percentage for monocytes from nor-
mal human donors (6). The total yield of migrat-
ing and nonmigrating monocytes was 75 to 90%
in a series of experiments. The attractant used
for the separations was a 1:500 dilution of a C5a
stock solution (6). After the separation proce-
dure, the migrating monocytes responded to
three different attractants, i.e., C5a, fMet-Leu-
Phe, and leukocyte-derived chemotactic factor;
the percentage of cells migrating was similar for
each attractant. Only 2 to 8% of the nonmigrat-
ing monocytes that were recovered from the top
of the chamber responded to attractant, and this
residual migration was eliminated after a second
separation step.
Binding of attractant to migrating and nonmi-
grating monocytes. The migrating and nonmi-
grating monocytes were incubated for 30 min at
24°C with concentrations of fMet-Leu-[3H]Phe
ranging from 10-9 to 10-7 M, with or without a
100-fold excess of the nonradioactive peptide.
There were 5 x 105 monocytes per tube. A
binding curve for the migrating monocytes is
shown in Fig. 2. Saturation was reached at an
attractant concentration of 5 x 10-8 M. Fifty-
percent of the maximal binding occurred at 10-8
M, the concentration that induces the optimal
monocyte chemotactic response. In eight ex-
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FIG. 2. Dose-response curve for the binding of
fMet-Leu-[3H]Phe to migrating monocytes separated
by migration to C5a. The migrating monocytes, 5 x
10-5/assay point, were incubated with the indicated
concentrations of the radioactive peptide in Gey bal-
anced salt solution containing 2% bovine serum albu-
min, with and without a 100-fold excess of the unla-
beled peptide. The total volume per tube was 1 ml.
After incubation for 30 min at 24°C, the cells were
centrifuged, and the supernatant was removed by
suction. The cells were then resuspended and trans-
ferred onto glass fiber filters. The cells were washed
with a large volume of medium, and the filter was then
transferred to a scintillation vial and counted after at
least 3 h of contact with the scintillation fluid. The
values are for single determinations.
periments, 5 x 105 nonmigrating monocytes
bound only 100 to 150 cpm, in contrast to 1,300
to 2,000 cpm for 5 x 105 migrating monocytes.
Since at least 80% of the cells in the nonmigrat-
ing population were lymphocytes, the minimal
binding shows that lymphocytes did not bind
fMet-Leu-[3H]Phe. The nonspecific binding,
measured with a 100-fold excess of the unlabeled
peptide, was less than 5% of the binding of the
labeled peptide alone. The counts bound to the
migrating monocytes represent 28 to 43 fmol of
peptide per 105 monocytes. An analysis of the
data by the method of Scatchard (13) yielded an
equilibrium dissociation constant (KD) ranging
from 23 to 37 nM in different experiments; the
number of binding sites per cell ranged from
64,000 to 77,000.
The binding data for migrating and unseparat-
ed monocytes were compared (Fig. 3). In this
experiment, a Ficoll-Hypaque preparation of
mononuclear cells was added to two separation
chambers, one with and the other without C5a in
the lower compartments. The cells that were
added to the chamber without the attractant
remained in the upper compartment, with the
exception of a small number of cells that moved
to the bottom of the filter by random migration;
these upper-compartment cells are designated
"unseparated." After a 70-min incubation peri-
od, we harvested the migrating monocytes from
the bottom of the attractant chamber filter and
the unseparated mononuclear cells from the
upper compartments of the control chamber.
Approximately 40% of the input monocytes mi-
grated to the bottom of the attractant chamber
filter. The binding of the radioactive attractant
was determined over the 10-9 to 10-7 M range
for aliquots of 5 x 105 monocytes from each cell
preparation. The counts per minute bound at
saturation for 5 x 105 unseparated monocytes
were about half that for 5 x 105 migrating
monocytes Fig. 3). This difference is consistent
with the fact that 60% of the unseparated mono-
cytes did not respond to attractant and with the
above finding that the nonmigrating monocytes
bound little or no attractant.
Kinetics of binding. The migrating monocytes
were incubated in 5 x 10-8 M radioactive pep-
tide for the times indicated in Fig. 4, which is
representative of three experiments. The bind-
ing reached equilibrium after about 20 min at
room temperature; 50% of the maximal binding
occurred at 3.5 min. The amount bound at 60
min was consistently slightly less than that
bound at 20 to 30 min. In a different experiment,
a 1,000-fold excess of the unlabeled peptide was
added at various times after the addition of the
labeled peptide, and 5 min thereafter the amount
of bound radioactivity was determined. When
the unlabeled peptide was added within 10 min
after the addition of the labeled peptide, 50% of
the bound counts were displaced. When the
interval was 20 min or more, only 20% of the
counts were displaced.
Effect of specific chemotactic deactivation on
binding. The effect of specific chemotactic deac-
tivation on binding was studied with unseparat-
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FIG. 3. Dose-response curves for the binding of
fMet-Leu-[3H]Phe to migrating (0) and unseparated
(0) monocytes. The protocol was the same as for the
experiment shown in Fig. 2.
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FIG. 4. Time course of binding. The experimental
procedure was as described in the legend to Fig. 2. The
concentration of fMet-Leu-[3H]Phe was 5 x 10-8 M.
The reaction was terminated at the indicated times by
centrifugation and resuspension in cold medium. The
points are means ± standard error of the mean for
duplicate determinations.
ed cell mixtures. Since only the migrating cells
bind the peptide, all changes measured can be
attributed to the migrating population. Mono-
cytes were deactivated with 5 x 10-7 M fMet-
Leu-Phe (see above) under conditions that
caused the deactivation of 65 to 90% of the cells
(7). Control cells were incubated in medium
without attractant. The cells were then washed,
and the binding of fMet-Leu-[3H]Phe was deter-
mined. The amount of radioactivity bound in 30
min by 2.5 x 106 control mononuclear cells was
3,100 cpm, whereas the same number of cells
that had been incubated with deactivating con-
centrations of the peptide bound 990 cpm.
DISCUSSION
Using a method that separates migrating from
nonmigrating populations ofhuman blood mono-
cytes, we have shown that the migrating cells
bound chemotactic peptide with a high affinity
(KD of 23 to 37 nM). The nonmigrating popula-
tion bound only small amounts of peptide, which
could be attributed to the small residual number
of migrating cells. Thus, the nonresponding cells
appear to lack the chemotaxin receptor. Addi-
tional deficiencies in subsequent stages of the
stimulus-response pathway have not been ruled
out. A quantitative comparison of migrating and
unseparated monocytes (Fig. 3) was consistent
with the above findings and showed that the lack
of peptide binding to the nonmigrated cells was
not secondary to C5a exposure during the sepa-
ration step.
It was shown recently that the human mono-
cyte-like cell line U937 expresses peptide recep-
tors only after stimulation with lymphokine-
containing supernatants (12). Cells that did not
respond to chemoattractant did not exhibit the
receptor. The maximum number of binding sites
for U937 was 33,000, and the KD was 15 to 30
nM. The number of sites is about half that
determined by us for human blood monocytes,
which may be due to the fact that the proportion
of migrating cells was not considered in the
calculations for the cell line.
We have previously shown that the chemotac-
tic deactivation of human monocytes is chemo-
taxin specific (6, 7). Deactivated cells are capa-
ble of responding normally to a different
attractant, indicating that the migration machin-
ery is intact and that the defect is at the level of
the specific receptor, either in ligand binding or
in postbinding transduction. In the present
study, we found a decrease in the capacity to
bind fMet-Leu-[3H]Phe after chemotactic deac-
tivation by fMet-Leu-Phe. This decrease in the
capacity to bind new peptide shows that there is
an alteration at the receptor, i.e., either contin-
ued occupancy by the deactivating peptide or
receptor removal.
The detection of receptor appearance and
disappearance may provide a tool for the investi-
gation of monocyte maturation and the biochem-
ical mechanisms of chemotaxis. For example,
does the absence of peptide receptors on the
nonmigrating human monocytes reflect a matu-
rational stage of the cells? The question can now
be approached experimentally. In this context,
the finding in the accompanying paper (10) is of
great interest. The binding of the chemotactic
peptide to the nonmigrating neutrophils is indis-
tinguishable from the binding to the unseparated
population that contains migrating and nonmi-
grating cells. Thus, the deficiency in human
neutrophils appears to be subsequent to recep-
tor-ligand binding. An investigation of these two
cell types offers the possibility of learning about
the transduction of information after ligand bind-
ing. Finally, our findings show that great care
must be taken in correlating biochemical data
from whole populations with chemotactic re-
sponses, since only a fraction of the whole
population may migrate.
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